Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apatinib Phase II in Advanced Colorectal Cancer
NCT01531777Phase 2Completed
- Sponsor
- Hengrui
- Start
- Apr 2011
- Primary completion
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Rivoceranib in colorectal cancer (CRC), sponsored by Hengrui. Started Apr 2011; status: completed.
02
Drugs
Rivoceranib
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT01531777.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01531777.